ArticleEuropean journal of pediatrics2026
SREBP gene polymorphisms and ambulatory blood pressure parameters in Chinese adolescents: a cross-sectional study.
Article in European journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
The purpose of this study was to investigate the association between SREBP gene polymorphisms and ambulatory blood pressure phenotypes. In the present study, 514 college students from a university in China were recruited. Questionnaire surveys, physical examinations, ambulatory blood pressure monitoring, and blood samples were collected. The relationship between SREBP gene polymorphisms and ambulatory blood pressure parameters in college students was analyzed using a multivariable linear regression model. A total of 510 students with complete data were included in the final analysis. After adjustment for sex, age, weight status, ethnicity, monthly household income per capita, salt intake habits, fruit intake frequency, vegetable intake frequency, smoking, alcohol consumption, history of hypertension, and waist circumference, SREBP1/rs11868035 was associated with 24-h SBP levels in college students under the additive and recessive genetic models (additive: β = 1.39, P = 0.045; recessive: β = 1.75, P = 0.027), but results were not significant after Bonferroni correction (P > 0.0167). Under the recessive genetic model, SREBP1/rs11868035 was associated with daytime SBP levels (β = 1.97, P = 0.026), and SREBP2/rs2228314 was positively associated with daytime DBP levels in college students (β = 2.44, P = 0.033), but neither remained significant after Bonferroni correction (P > 0.0167).
conclusionSREBP gene polymorphisms exhibited suggestive associations with ambulatory blood pressure in Chinese adolescents. Although the associations were not significant after multiple testing correction, these findings suggest potential genetic influences on blood pressure regulation in youth and may inform future research on genetically informed approaches to hypertension prevention. WHAT IS KNOWN: • Accumulating evidence has demonstrated associations between SREBP gene polymorphisms and cardiometabolic phenotypes. • To date, no studies have investigated the association between SREBP gene polymorphisms and ambulatory blood pressure phenotypes. WHAT IS NEW: • In this exploratory analysis, we identified an association between the rs11868035 polymorphism in the SREBP1 gene and ambulatory blood pressure phenotypes, including 24-h and daytime systolic blood pressure, among Chinese adolescents. • The SREBP1/rs11868035 polymorphism appears to be associated with higher 24-h and daytime systolic blood pressure, whereas the SREBP2/rs2228314 polymorphism was positively associated with daytime diastolic blood pressure.
Indexed as
Identifiers
42301492What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.